Real-World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients

Keyphrases

• Confidence Interval 100%
• Head-and-neck 100%
• Real-world Outcomes 100%
• Melanoma Patients 100%
• Hazard Ratio 83%
• Overall Survival 83%
• Prognostic Factors 33%
• Metastatic Melanoma 33%
• Primary Tumor Site 33%
• Lactate Dehydrogenase 33%
• Oncological Treatment 33%
• Eastern Cooperative Oncology Group Performance Status (ECOG PS) 33%
• Patient Characteristics 16%
• Melanoma 16%
• Multivariable 16%
• Adverse Events 16%
• Cox Regression Analysis 16%
• Medical Files 16%
• Laryngoscope 16%
• Bioelectronic Medicine 16%
• Kaplan-Meier 16%
• Targeted Therapy 16%
• Systemic Treatment 16%
• Head-and-neck Region 16%
• Tumor Factor 16%
• Multi-institutional Study 16%
• Median Overall Survival 16%
• Site of Disease 16%
• Severe Adverse Events 16%
• Neck Region 16%
• Survival Regression Analysis 16%
• Univariable Analysis 16%

Medicine and Dentistry

• Nodular Melanoma 100%
• Neck 100%
• Overall Survival 100%
• Hazard Ratio 83%
• Disease 33%
• Adverse Event 33%
• Oncology 33%
• Prognostic Factor 33%
• Cutaneous Melanoma 33%
• Lactate Dehydrogenase 33%
• Nape 33%
• Neoplasm 16%
• Proportional Hazards Model 16%
• Primary Tumor 16%
• Immunotherapy 16%
• Targeted Therapy 16%
• Systemic Therapy 16%